What is the current Oncternal Therapeutics share price?
The current share price of Oncternal Therapeutics is US$ 0.5266
How many Oncternal Therapeutics shares are in issue?
Oncternal Therapeutics has 2,959,645 shares in issue
What is the market cap of Oncternal Therapeutics?
The market capitalisation of Oncternal Therapeutics is USD 1.56M
What is the 1 year trading range for Oncternal Therapeutics share price?
Oncternal Therapeutics has traded in the range of US$ 0.5266 to US$ 10.613 during the past year
What is the PE ratio of Oncternal Therapeutics?
The price to earnings ratio of Oncternal Therapeutics is -0.04
What is the cash to sales ratio of Oncternal Therapeutics?
The cash to sales ratio of Oncternal Therapeutics is 2
What is the reporting currency for Oncternal Therapeutics?
Oncternal Therapeutics reports financial results in USD
What is the latest annual turnover for Oncternal Therapeutics?
The latest annual turnover of Oncternal Therapeutics is USD 785k
What is the latest annual profit for Oncternal Therapeutics?
The latest annual profit of Oncternal Therapeutics is USD -39.48M
What is the registered address of Oncternal Therapeutics?
The registered address for Oncternal Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Oncternal Therapeutics website address?
The website address for Oncternal Therapeutics is www.oncternal.com
Which industry sector does Oncternal Therapeutics operate in?
Oncternal Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
